模拟失重增强大鼠脑动脉血管平滑肌细胞大电导钙激活钾通道功能

本工作旨在探讨短期模拟失重大鼠脑动脉血管平滑肌细胞（vascular smooth muscle cells,VSMCs）大电导钙激活钾通道（large conductance calcium-activated potassium channels,BKCa channels）功能的改变。以尾部悬吊大鼠模型模拟失重对脑血管的影响。应用激光扫描共聚焦显微镜测定VSMCs胞内游离钙浓度（[Ca^2＋]i）;采用细胞贴附模式,记录BKCa通道的单通道活动。结果表明,模拟失重1周后,大鼠脑动脉VSMCs的[Ca^2＋]i比对照组显著升高（P〈0．05）：BKCa通道的开放概率（Po）与平均开放时间（To）显著增加（P〈0．05）,而单通道电导与平均关闭时间（Tc）则无显著变化。总之,1周模拟失重可引起脑动脉VSMCs的BKCa通道功能显著增强,且与细胞[Ca^2＋]i的升高同步出现。结果提示,脑动脉VSMCs的离子通道机制可能参与介导模拟失重引起的脑血管适应性变化。     

四周模拟失重大鼠后身动脉平滑肌细胞钾电流的改变

本文采用全细胞膜片钳方法观察4周尾部悬吊大鼠（tail-suspended rats,SUS)隐动脉及肠系膜的动脉第2-6级动脉分支血管平滑肌细胞（vascular smooth muscle cells,VSMCs)钾电流密度的变化,结果表明：SUS大鼠后身动脉VSMCs的静息电位（RP）较对照大鼠（CON）后身动脉VSMCs的RP更负,SUS组隐动脉和肠系膜小鼠后身动脉VSMCs的静息电位（RP）较对照大鼠（CON）后身动脉VSMCs的RP更负,SUS组隐动脉和肠系膜小动脉VSMCs的全细胞钾电流密度较CON组显著增加,其中,SUS组的隐动脉和肠系膜小动脉VSMCs的大电导钙激活钙离子通道（BKca)和电压激活钾离子通道（Kv)电流密度较CON组的BKca和Kv电流密度均显著增加,以上结果提示,VSMCs的超极化及进一步引起的通过电压依赖性钙离子通道的钙内流减少可能是模拟失重引起后身动脉反应性降低的电生理机制之一。     

短期模拟失重可增强大鼠脑动脉平滑肌细胞L-型Ca~(2+)通道对血管紧张素Ⅱ的反应性

已有研究表明模拟失重可引起大鼠脑动脉发生区域特异性变化,其中Ca2+通道和肾素-血管紧张素系统(renin-angio-tensin system,RAS)可能发挥着重要的作用。本研究旨在探讨血管紧张素Ⅱ(angiotensin Ⅱ,Ang Ⅱ)对短期模拟失重大鼠脑基底动脉血管平滑肌细胞(vascular smooth muscle cells,VSMCs)L-型Ca2+通道(L-type calcium channel,CaL)功能的影响。模拟失重(尾部悬吊)3d后,用木瓜蛋白酶法分离大鼠脑基底动脉VSMCs。采用全细胞膜片钳技术,以Ba2+作为载流子,测定CaL电流密度,然后观察Ang Ⅱ对该电流的影响。结果显示,模拟失重3d对大鼠脑基底动脉VSMCs的膜电容和接入电阻无明显影响,但可致VSMCs的CaL电流密度显著增加。不过,模拟失重对CaL的电压激活特性和稳态激活曲线亦无明显影响。对照组和模拟失重组大鼠脑基底动脉VSMCs的CaL电流密度在给予Ang Ⅱ处理后均显著增加,且模拟失重组的增加幅度显著大于对照组。以上结果提示,3d短期模拟失重即可引起大鼠脑动脉VSMCs的CaL发生适应性改变,且可导致其对...     

间断性人工重力对模拟失重大鼠颈总动脉平滑肌细胞凋亡的影响

目的:研究3周模拟失重大鼠颈总动脉平滑肌细胞凋亡的变化及间断性人工重力对其的影响。方法:以尾部悬吊大鼠(SUS)模拟失重,同期每天悬吊23h、站立1h(STD)模拟间断性人工重力的对抗效果,用M30染色及Tunel染色方法观察3周SUS组、同步对照(CON)组及STD组颈总动脉平滑肌细胞早期和中晚期的凋亡情况,并用免疫组织化学方法及Western blot印迹方法观察各组大鼠颈总动脉组织Caspase-3的蛋白表达变化。结果:与CON组比较,SUS组大鼠颈总动脉平滑肌细胞M30染色阳性细胞明显减少,STD组M30染色阳性细胞较CON组及SUS组显著增加;SUS组Tunel染色阳性细胞较CON组及STD组显著减少,STD组Tunel染色阳性细胞较CON组及SUS组显著增加;SUS组Caspase-3的表达较CON组显著降低(P<0.05),STD组Caspase-3的表达较CON组及SUS组显著增高(P<0.01)。结论:模拟失重可引起大鼠颈总动脉平滑肌细胞凋亡减少,每日1 h的-Gx对抗使颈总动脉的凋亡增加。Caspase-3可能在调控模拟失重所致血管组织平滑肌细胞的凋亡中发挥作用。     

失血性休克引起大鼠肠系膜动脉平滑肌依钙K^＋通道活动改变

在由股动脉放血制备的失血性休克大鼠模型急性分离的肠系膜动脉平滑肌细胞上,利用膜片箝单通道记录技术观察了血管平滑肌依钙K^ 通道（BKca)的活动,发现在对去甲肾上腺素（NE）反应性增高的休克代偿期,BKca的开放概率（P0)和单位电导都显著较正常动物的低,P0的改变主要是由通道的慢关闭时间常数（τcs)增大引起关闭时间延长所致;而处于对NE反应性降低的休克失代偿期,BKca的P0和单位电导都高于正常动物,P0的变化也主要是τcs减小所致。     

失血性休克引起大鼠肠系膜动脉平滑肌依钙K~ 通道活动改变

在由股动脉放血制备的失血性休克大鼠模型急性分离的肠系膜动脉平滑肌细胞上 ,利用膜片箝单通道记录技术观察了血管平滑肌依钙K 通道 (BKCa)的活动。发现在对去甲肾上腺素 (NE)反应性增高的休克代偿期 ,BKCa的开放概率 (Po)和单位电导都显著较正常动物的低 ,Po 的改变主要是由通道的慢关闭时间常数 (τcs)增大引起关闭时间延长所致 ;而处于对NE反应性降低的休克失代偿期 ,BKCa的Po 和单位电导都高于正常动物 ,Po的变化也主要是τcs减小所致。     

内皮细胞电压门控钙离子通道及其功能研究进展

内皮细胞（endothelial cell,EC）作为不可兴奋细胞,早前通常被认为缺乏功能性电压门控钙离子通道（voltagegated calcium channel,VGCC）,如人脐静脉内皮细胞、牛肺动脉内皮细胞、牛主动脉内皮细胞等。随着膜片钳技术、荧光显微技术、聚合酶链式反应（PCR）技术的发展,越来越多的VGCC在各种内皮细胞中被发现,如人主动脉内皮细胞、大鼠主动脉内皮细胞、大鼠肺微血管内皮细胞等。目前对于VGCC存在与否主要有3种检测方法:利用膜片钳技术对离子通道电流的检测、利用荧光显微技术对胞内钙离子浓度变化的检测、利用PCR技术对离子通道基因或蛋白质表达的检测。内皮细胞不单单是血液和其他相邻组织细胞及基质蛋白间的物理屏障,更重要的是通过细胞膜上VGCC的开放和关闭对细胞和血管组织的生理变化产生显著的影响。一方面,VGCC对胞内钙离子浓度变化的影响,控制着一氧化氮（NO）等血管舒张因子的释放,调节血管张力的平衡。另一方面,作为钙离子内流重要途经的VGCC,经过Ras和MEK通路的诱导、磷酸化PI3K和Akt通路,影响内皮细胞迁移和增殖。此外,部分生理现象,如血管内压力产生...     

血管钠肽对大鼠肠系膜动脉平滑肌细胞Ca2+激活K+通道的作用

目的研究血管钠肽(VNP)对大鼠肠系膜动脉血管平滑肌细胞(VSMCs)Ca2+激活K+通道(Kca)的作用及其机制.方法采用全细胞膜片钳技术观察VNP对Kca的影响,以及HS-142-1、8-Br-cGMP和美蓝(MB)在这一过程中的作用.结果①VNP(10-6 mol/L)显著增强Kca(P＜0.05,n=5).②8-Br-CGMP(10-3mol/L)模拟VNP增强Kca的作用(P＜0.05,n=6).③HS-142-1(2×10-5mol/L)或MB(10-5mol/L)完全阻断VNP增加Kca电流密度的作用.结论VNP通过作用于VSMCs的钠尿肽GC耦联受体,升高细胞内的cGMP水平,激活Kca.     

川芎嗪对大鼠胸主动脉平滑肌电压依赖性Cl-通道的影响

川芎嗪(即四甲基吡嗪tetramethylpyrazine)是从具有活血化淤兼有理气功用中药川芎中分离得到的一种生物碱,现已广泛应用临床,对治疗缺血性脑血管疾病、缺血性肢体血管疾病、部分泌尿系统疾病等有明显的疗效,安全而无明显的毒副作用.有作者报道川芎嗪有明显抑制α1-肾上腺受体激动所引起持续血管收缩,而使血管舒张作用,可能与其有类似的"钙通道阻断剂"作用有关.目前认为血管平滑肌的张力与钙、钾和氯通道有关,川芎嗪与钾和氯通道的关系目前未见报道. 1 材料与方法 (1)药物川芎嗪,无锡市第七制药厂生产;DMEM,DIDS,HEPES,胰蛋白酶,EGTA,硝苯地平(nifedipine),苯肾上腺素(简称PHE)均为 Sigma公司出品,其余试剂均为市场销售的分析纯试剂.均为美国Sigma公司产品;其余的试剂均为国产分析纯.     

血管平滑肌细胞上的自发内向阳离子通道

采用膜片箝技术的细胞贴附式（ｃｅｌ－ａｔａｃｈｅｄ）,在酶法分离的大鼠尾动脉平滑肌细胞上记录到一种自发的内向阳离子通道。结果发现：１、在实验条件下（池子液：Ｋｒｅｂｓ,电极液：高钾）,该通道电导为２６．５±４．１ｐＳ,且具有明显的电压依赖、时间依赖和Ｃａ２＋依赖的特性;２、该电流具有极显著的内向整流特性;３、离子替换实验表明,该通道对Ｎａ＋和Ｋ＋具有很好的通透性,对Ｃｌ－的通透则很差;４、胞外加入４－ＡＰ（２ｍｍｏｌ／Ｌ或５ｍｍｏｌ／Ｌ）,ＢａＣｌ２（１ｍｍｏｌ／Ｌ）和ＣｓＣｌ（２０ｍｍｏｌ／Ｌ）均不能抑制该电流;５、内向阳离子电流可与Ｃａ２＋－激活Ｋ＋电流在同一细胞上交替活动,提示这两种电流可能在调控平滑肌细胞的基本活动方面起关键作用。     

Resident phenotypically modulated vascular smooth muscle cells in healthy human arteries

Vascular interstitial cells (VICs) are non‐contractile cells with filopodia previously described in healthy blood vessels of rodents and their function remains unknown. The objective of this study was to identify VICs in human arteries and to ascertain their role. VICs were identified in the wall of human gastro‐omental arteries using transmission electron microscopy. Isolated VICs showed ability to form new and elongate existing filopodia and actively change body shape. Most importantly sprouting VICs were also observed in cell dispersal. RT‐PCR performed on separately collected contractile vascular smooth muscle cells (VSMCs) and VICs showed that both cell types expressed the gene for smooth muscle myosin heavy chain (SM‐MHC). Immunofluorescent labelling showed that both VSMCs and VICs had similar fluorescence for SM‐MHC and αSM‐actin, VICs, however, had significantly lower fluorescence for smoothelin, myosin light chain kinase, h‐calponin and SM22α. It was also found that VICs do not have cytoskeleton as rigid as in contractile VSMCs. VICs express number of VSMC‐specific proteins and display features of phenotypically modulated VSMCs with increased migratory abilities. VICs, therefore represent resident phenotypically modulated VSMCs that are present in human arteries under normal physiological conditions.     

Properties of calcium channels in cardiac muscle and vascular smooth muscle

The voltage-dependent slow channels in the myocardial cell membrane are the major pathway by which Ca²⁺ ions enter the cell during excitation for initiation and regulation of the force of contraction of cardiac muscle. The slow channels have some special properties, including functional dependence on metabolic energy, selective blockade by acidosis, and regulation by the intracellular cyclic nucleotide levels. Because of these special properties of the slow channels, Ca²⁺ influx into the myocardial cell can be controlled by extrinsic factors (such as autonomic nerve stimulation or circulating hormones) and by intrinsic factors (such as cellular pH or ATP level). The slow Ca²⁺ channels of the heart are regulated by cAMP in a stimulatory fashion. Elevation of cAMP produces a very rapid increase in number of slow channels available for voltage activation during excitation. The probability of a slow channel opening and the mean open time of the channel are increased. Therefore, any agent that increases the cAMP level of the myocardial cell will tend to potentiate I_si, Ca²⁺ influx, and contraction. The myocardial slow Ca²⁺ channels are also regulated by cGMP, in a manner that is opposite to that of CAMP. The effect of cGMP is presumably mediated by means of phosphorylation of a protein, as for example, a regulatory protein (inhibitory-type) associated with the slow channel. Preliminary data suggest that calmodulin also may play a role in regulation of the myocardial slow Ca²⁺ channels, possibly mediated by the Ca²⁺-calmodulin-protein kinase and phosphorylation of some regulatory-type of protein. Thus, it appears that the slow Ca²⁺ channel is a complex structure, including perhaps several associated regulatory proteins, which can be regulated by a number of extrinsic and intrinsic factors.VSM cells contain two types of Ca²⁺ channels: slow (L-type) Ca²⁺ channels and fast (T-type) Ca²⁺ channels. Although regulation of voltage-dependent Ca²⁺ slow channels of VSM cells have not been fully clarified yet, we have made some progress towards answering this question. Slow (L-type, high-threshold) Ca²⁺ channels may be modified by phosphorylation of the channel protein or an associated regulatory protein. In contrast to cardiac muscle where cAMP and cGMP have antagonistic effects on Ca²⁺ slow channel activity, in VSM, cAMP and cGMP have similar effects, namely inhibition of the Ca²⁺ slow channels. Thus, any agent that elevates cAMP or cGMP will inhibit Ca²⁺ influx, and thereby act to produce vasodilation. The Ca²⁺ slow channels require ATP for activity, with a K_0.5 of about 0.3 mM. C-kinase may stimulate the Ca²⁺ slow channels by phosphorylation. G-protein may have a direct action on the Ca²⁺ channels, and may mediate the effects of activation of some receptors. These mechanisms of Ca²⁺ channel regulation may be invoked during exposure to agonists or drugs, which change second messenger levels, thereby controlling vascular tone.     

Measurement of whole-cell calcium current in voltage-clamped vascular muscle cells

The direct measurement of transmembrane calcium current in single vascular muscle cells has been accomplished recently using the whole-cell voltage-clamp technique. The small size of the vascular muscle cell and the proportionately smaller magnitude of its inward calcium current necessitate refined instrumentation, but also make the vascular muscle cell an ideal candidate for whole-cell voltage-clamp recording. Calcium current in vascular muscle cells appears to have some, but not all, characteristics in common with calcium currents similarly isolated in neuronal and cardiac cells, including voltage-dependent activation and steady-state inactivation of calcium current, the presence of two current types, and sensitivity to inorganic and organic calcium channel modulating drugs. Future voltage-clamp analysis of calcium currents in vascular muscle is needed to further our understanding of the control of the calcium channels in physiological and pathophysiological states.     

Hyperosmolality-induced abnormal patterns of calcium mobilization in smooth muscle cells from non-diabetic and diabetic rats

Hyperglycemia and/or hyperosmolality may disturb calcium homeostasis in vascular smooth muscle cells (SMCs), leading to altered vascular contractility in diabetes. To test this hypothesis, the KCl induced increases in [Ca²⁺]_i in primarily cultured vascular SMCs exposed to different concentrations of glucose were examined. With glucose concentration in solutions kept at 5.5 mM, KCl induced a fast increase in [Ca²⁺]_i which then slowly declined (type 1 response) in 83% of SMCs from non-diabetic rats. In 9% of non-diabetic SMCs KCl induced a slow increase in [Ca²⁺]_i (type 2 response). Interestingly, under the same culture conditions KCl induced type 1 and type 2 responses in 47 and 35% of SMCs from diabetic rats. When SMCs from non-diabetic or diabetic rats were cultured in 36 mM glucose, KCl induced a fast increase in [Ca²⁺]_i which, however, maintained at a high level (type 3 response). The sustained level of [Ca²⁺]_i in the presence of KCl was significantly higher in cells cultured with 36 mM glucose than that in non-diabetic cells cultured with 5.5 mM glucose. Furthermore, the hyperglycemia-induced alterations in calcium mobilization were similarly observed in cells cultured in high concentration of mannitol (30.5 mM) or L-glucose, indicating that hyperosmolality was mainly responsible for the abnormal calcium mobilization in diabetic SMCs.     

不同牵张刺激对豚鼠胃窦环行肌细胞电压依赖性钙电流的影响

利用全细胞膜片钳技术,在胃窦环行肌细胞上观察了不同方式的牵张刺激对电压依赖性钙电流的影响,探讨牵张刺激对胃窦平滑肌细胞电压依赖性钙电流的作用。用低渗性溶液灌流细胞引起的牵张刺激首先增加电压依赖性钙电流,接着激活一种内向性钳制电流。钙电流的增加发生在灌流后１ｍｉｎ内,而内向性钳制电流在细胞明显膨胀之后缓慢激活。低渗和正压引起的细胞膨胀明显增加电压依赖性钙离子电流,而利用两个电极直接牵细胞则不出现钙电     

Osteogenic transdifferentiation of vascular smooth muscle cells isolated from spontaneously hypertensive rats and potential menaquinone-4 inhibiting effect

Vascular calcification (VC) is an active and cell-mediated process that shares many common features with osteogenesis. Knowledge demonstrates that in the presence of risk factors, such as hypertension, vascular smooth muscle cells (vSMCs) lose their contractile phenotype and transdifferentiate into osteoblastic-like cells, contributing to VC development. Recently, menaquinones (MKs), also known as Vitamin K2 family, has been revealed to play an important role in cardiovascular health by decreasing VC. However, the MKs' effects and mechanisms potentially involved in vSMCs osteoblastic transdifferentiation are still unknown. The aim of this study was to investigate the possible role of menaquinone-4 (MK-4), an isoform of MKs family, in the modulation of the vSMCs phenotype. To achieve this, vascular cells from spontaneously hypertensive rats (SHR) were used as an in vitro model of cell vascular dysfunction. vSMCs from Wistar Kyoto normotensive rats were used as control condition. The results showed that MK-4 preserves the contractile phenotype both in control and SHR-vSMCs through a γ-glutamyl carboxylase-dependent pathway, highlighting its capability to inhibit one of the mechanisms underlying VC process. Therefore, MK-4 may have an important role in the prevention of vascular dysfunction and atherosclerosis, encouraging further in-depth studies to confirm its use as a natural food supplement.